DescriptionHepassocin/FGL1 Monoclonal specifically detects Hepassocin/FGL1 in Human samples. It is validated for Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready.
|Intracellular Staining by Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready|
|Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.|
|FGL1, fibrinogen-like 1, fibrinogen-like protein 1, Fibrinogen-like-protein 1, FREP1, Hepassocin, hepatocellular carcinoma-related sequence, Hepatocyte-derived fibrinogen-related protein 1, HFREP-1, HFREP1MGC12455, HP-041, LFIRE1, LFIRE-1, Liver fibrinogen-related protein 1|
|Mouse myeloma cell line NS0-derived recombinant human Hepassocin/FGL1, Met1-Ile312, Accession # BAB70690|
|Reconstitute at 0.5 mg/mL in sterile PBS.|
|Flow Cytometry, Immunocytochemistry, CyTOF|
|Protein A or G purified from hybridoma culture supernatant|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok